therapeutic areas banner
Our therapies mobile banner

GIVLAARI® (givosiran) - Alnylam Therapies

Select below to explore a breadth of educational, scientific, and clinical resources related to the FDA-approved uses of our therapies.

 Resources

View Full Prescribing Information

Explore clinical and educational resources related to the use of givosiran in adult patients with acute hepatic porphyria (AHP)

long-term-assessment-of-patients

Infographic

Long-term Assessment of Patients with AHP and AIP who were Not Attack-Free after 6-Months of Givosiran Treatment: A Post Hoc Subgroup Analysis of the Phase 3 ENVISION Study

An infographic depicting a post-hoc analysis of the ENVISION phase 3 study to understand the long-term clinical outcomes of patients who were not attack free after 6-months of givosiran treatment.

View Material

Explore Additional Resources & Support

Ahp-givlaari

Acute Hepatic Porphyria (AHP)

Learn more about Acute Hepatic Porphyria (AHP)

purple circle arrow
medical call icon

Connect with Alnylam Medical

Reach our medical team for scientific information, resources, and support

blue circle arrow